Excerpted USP-NF and FCC Standards: a Hand Sanitizer Resource

Total Page:16

File Type:pdf, Size:1020Kb

Excerpted USP-NF and FCC Standards: a Hand Sanitizer Resource Not official text. Please refer to the currently official version of the applicable USP–NF or FCC standard for compliance purposes. Excerpted USP-NF and FCC Standards: A Hand Sanitizer Resource A collection of standards provided as a resource to assist with the challenges posed by COVID-19 Not official text. Please refer to the currently official version of the applicable USP–NF or FCC standard for compliance purposes. Published August 17, 2020 Not official text. Please refer to the currently official version of the applicable USP–NF or FCC standard for compliance purposes. CONTENTS USP Monographs…………………………………………………………………15 • Alcohol • Dehydrated Alcohol • Azeotropic Isopropyl Alcohol • Glycerin • Hydrogen Peroxide Concentrate • Hydrogen Peroxide Topical Solution • Isopropyl Alcohol • Purified Water Excipients………………………………………………………………………… 25 • USP and NF Excipients, Listed by Functional Category NF Monographs…………………………………………………………………. 37 • Denatonium Benzoate • Sucrose Octaacetate Reference Tables……………………………………………………………….. 39 • Alcoholometric Table Food Chemicals Codex……………………………………………………… 119 • Ethyl Alcohol • Glycerin • Hydrogen Peroxide • Isopropyl Alcohol Additional documentary standards are also included in this publication to support these highlighted standards. Published August 17, 2020 Not official text. Please refer to the currently official version of the applicable USP–NF or FCC standard for compliance purposes. Published August 17, 2020 Not official text. Please refer to the currently official version of the applicable USP–NF or FCC standard for compliance purposes. 3 GENERAL NOTICES AND REQUIREMENTS Applying to Standards, Tests, Assays, and Other Specifications of the United States Pharmacopeia 1. TITLE AND REVISION................................................. 5 8. TERMS AND DEFINITIONS....................................... 11 8.10. Abbreviations.................................................... 11 2. OFFICIAL STATUS AND LEGAL RECOGNITION........ 5 8.20. About................................................................ 11 2.10. Official Text......................................................... 5 8.30. Alcohol Content................................................ 11 2.20. Official Articles..................................................... 5 8.40. Atomic Weights................................................. 11 2.30. Legal Recognition................................................ 5 8.50. Blank Determinations........................................ 12 8.60. Concomitantly................................................... 12 3. CONFORMANCE TO STANDARDS............................. 5 8.70. Desiccator......................................................... 12 3.10. Applicability of Standards.................................... 5 8.80. Logarithms........................................................ 12 3.20. Indicating Conformance...................................... 6 8.90. Microbial Strain................................................. 12 8.100. Negligible........................................................ 12 4. MONOGRAPHS AND GENERAL CHAPTERS.............. 7 8.110. NLT/NMT........................................................ 12 4.10. Monographs........................................................ 7 8.120. Odor............................................................... 12 4.20. General Chapters................................................. 7 8.130. Percent............................................................ 12 8.140. Percentage Concentrations.............................. 12 5. MONOGRAPH COMPONENTS................................... 7 8.150. Pressure........................................................... 12 5.10. Molecular Formula............................................... 7 8.160. Reaction Time.................................................. 12 5.20. Added Substances............................................... 7 8.170. Specific Gravity................................................ 12 5.30. Description and Solubility.................................... 8 8.180. Temperatures.................................................. 12 5.40. Identification....................................................... 8 8.190. Time................................................................ 12 5.50. Assay................................................................... 8 8.200. Transfer........................................................... 12 5.60. Impurities and Foreign Substances....................... 9 8.210. Vacuum........................................................... 12 5.70. Performance Tests............................................... 9 8.220. Vacuum Desiccator.......................................... 12 5.80. USP Reference Standards..................................... 9 8.230. Water.............................................................. 13 8.240. Weights and Measures..................................... 13 6. TESTING PRACTICES AND PROCEDURES................. 9 6.10. Safe Laboratory Practices..................................... 9 9. PRESCRIBING AND DISPENSING............................. 14 6.20. Automated Procedures........................................ 9 9.10. Use of Metric Units............................................ 14 6.30. Alternative and Harmonized Methods and Procedures.......................................................... 9 10. PRESERVATION, PACKAGING, STORAGE, AND 6.40. Dried, Anhydrous, Ignited, or Solvent-Free Basis 10 LABELING.................................................................. 14 6.50. Preparation of Solutions..................................... 10 10.10. Packaging and Storage.................................... 14 6.60. Units Necessary to Complete a Test................... 10 10.20. Labeling.......................................................... 14 6.70. Reagents........................................................... 10 6.80. Equipment......................................................... 11 7. TEST RESULTS.......................................................... 11 7.10. Interpretation of Requirements.......................... 11 7.20. Rounding Rules................................................. 11 Published August 17, 2020 Not official text. Please refer to the currently official version of the applicable USP–NF or FCC standard for compliance purposes. Published August 17, 2020 Not official text. Please refer to the currently official version of the applicable USP–NF or FCC standard for compliance purposes. 5 GENERAL NOTICES AND REQUIREMENTS The General Notices and Requirements section (the General 2.20. Official Articles Notices) presents the basic assumptions, definitions, and An official article is an article that is recognized in USP or NF. default conditions for the interpretation and application of the An article is deemed to be recognized and included in a United States Pharmacopeia (USP) and the National Formulary compendium when a monograph for the article is published (NF). in the compendium and an official date is generally or Requirements stated in these General Notices apply to all specifically assigned to the monograph. articles recognized in the USP and NF (the “compendia”) and The title specified in a monograph is the official title for such to all general chapters unless specifically stated otherwise. article. Other names considered to be synonyms of the official titles may not be used as substitutes for official titles. For drug products that incorporate a sensor to detect that the product Change to read: has been administered, the official title shall be the title 1. TITLE AND REVISION specified in the relevant drug product monograph plus the ▲ words “with sensor”. The full title of this joint compendium is The Pharmacopeia Official articles include both official substances and official of the United States of America and the National Formulary products. An official substance is a drug substance, excipient, Online (USP–NF Online). Although USP and NF are published dietary ingredient, other ingredient, or component of a together and share these General Notices, they are separate finished device for which the monograph title includes no compendia. This is the 43rd revision of the USP and 38th indication of the nature of the finished form. edition of the NF. The final print publication of the USP–NF is An official product is a drug product, dietary supplement, USP 43–NF 38, after which official standards are published compounded preparation, or finished device for which a only in the USP–NF Online. Where the terms “USP,” “NF,” or monograph is provided. “USP–NF” are used without further qualification, they refer to 2.30. Legal Recognition the currently official standard.▲ (USP 1-Aug-2020) The USP and NF are recognized in the laws and regulations of many countries throughout the world. Regulatory authorities may enforce the standards presented in the USP Change to read: and NF, but because recognition of the USP and NF may vary 2. OFFICIAL STATUS AND LEGAL RECOGNITION by country, users should understand applicable laws and regulations. In the United States under the Federal Food, Drug, 2.10. Official Text and Cosmetic Act (FDCA), both USP and NF are recognized as Official text of the USP and NF is published in the USP–NF ▲ official compendia. A drug with a name recognized in USP–NF Online (www.uspnf.com). ▲ (USP 1-Aug-2020) must comply with compendial identity standards or be Routine revisions are published in the USP–NF Online and deemed adulterated, misbranded,
Recommended publications
  • GRAS Notice 789 for Erythritol
    GRAS Notice (GRN) No. 789 https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory. Toi• Strategies ~~~~G~~[)) JUN 7 20'8 Innovative solutions Sound science OFFICE OF FOOD ADDITIVE SAFE1Y June 5, 2018 Dr. Dennis Keefe Director, Division of Biotechnology and GRAS Notice Review Office of Food Additive Safety (HFS-200) Center for Food Safety and Applied Nutrition Food and Drug Administration 5100 Paint Branch Parkway College Park, MD 20740-3835 Subject: GRAS Notification - Erythritol Dear Dr. Keefe: On behalf of Cargill, Incorporated, ToxStrategies, Inc. (its agent) is submitting, for FDA review, a copy of the GRAS notification as required. The enclosed document provides notice of a claim that the food ingredient, erythritol, described in the enclosed notification is exempt from the premarket approval requirement of the Federal Food, Drug, and Cosmetic Act because it has been determined to be generally recognized as safe (GRAS), based on scientific procedures, for addition to food. If you have any questions or require additional information, please do not hesitate to contact me at 630-352-0303, or [email protected]. Sincerely, (b) (6) Donald F. Schmitt, M.P.H. Senior Managing Scientist ToxStrategies, Inc., 931 W. 75th St. , Suite 137, PMB 263, Naperville, IL 60565 1 Office (630) 352-0303 • www.toxstrategies.com GRAS Determination of Erythritol for Use in Human Food JUNES,2018 Innovative solutions s ,..,.,',--.r-.r--.r--. OFFICE OF FOOD ADDITIVE SAFE1Y GRAS Determination of Erythritol for Use in Human Food SUBMITTED BY: Cargill, Incorporated 15407 McGinty Road West Wayzata, MN 55391 SUBMITTED TO: U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food Additive Safety HFS-200 5100 Paint Branch Parkway College Park MD 20740-3835 CONTACT FOR TECHNICAL OR OTIIER INFORMATION Donald F.
    [Show full text]
  • Notice of Modification to the List of Permitted Food Enzymesto Enable
    Notice of Modification to the List of Permitted Food Enzymes to Enable the Use of Lysophospholipase from Trichoderma reesei RF7206 in the Production of Sugars and Dextrins from Starch Notice of Modification – Lists of Permitted Food Additives Reference Number: NOM/ADM-0172 August 10, 2021 Summary Food additives are regulated in Canada under Marketing Authorizations (MAs) issued by the Minister of Health and the Food and Drug Regulations (Regulations). Approved food additives and their permitted conditions of use are set out in the Lists of Permitted Food Additives that are incorporated by reference in the MAs and published on the Canada.ca website. A petitioner can request that Health Canada approve a new additive or a new condition of use for an already approved food additive by filing a food additive submission with the Department's Food Directorate. Health Canada uses this premarket approval process to determine whether the scientific data support the safety of food additives when used under specified conditions in foods sold in Canada. Health Canada’s Food Directorate received a food additive submission seeking approval for the use of lysophospholipase from Trichoderma reesei RF7206 in starch used in the production of dextrins, dextrose, fructose syrups and solids, glucose (glucose syrup), glucose solids (dried glucose syrup), or maltose. The food enzyme is intended to be used at a level consistent with Good Manufacturing Practice1. Its purpose of use is to improve the efficiency of the starch processing. Lysophospholipase is a type of phospholipase. Phospholipase from other microbial sources is already permitted for use in Canada as a food enzyme in certain foods, but not in the production of sugars and dextrins from starch.
    [Show full text]
  • “Polyols: a Primer for Dietetic Professionals” Is a Self-Study
    1 “Polyols: A primer for dietetic professionals” is a self-study module produced by the Calorie Control Council, an accredited provider of continuing professional education (CPE) for dietetic professionals by the Commission on Dietetic Registration. It provides one hour of level 1 CPE credit for dietetic professionals. The full text of the module is in the notes section of each page, and is accompanied by summary points and/or visuals in the box at the top of the page. Directions for obtaining CPE are provided at the end of the module. 2 After completing this module, dietetic professionals will be able to: • Define polyols. • Identify the various types of polyols found in foods. • Understand the uses and health effects of polyols in foods. • Counsel clients on how to incorporate polyols into an overall healthful eating pattern. 3 4 Polyols are carbohydrates that are hydrogenated, meaning that a hydroxyl group replaces the aldehyde or ketone group found on sugars. Hydrogenated monosaccharides include erythritol, xylitol, sorbitol, and mannitol. Hydrogenated disaccharides include lactitol, isomalt, and maltitol. And hydrogenated starch hydrolysates (HSH), or polyglycitols (a wide range of corn syrups and maltodextrins), are formed from polysaccharides (Grabitske and Slavin 2008). 5 Nearly 54 percent of Americans are trying to lose weight, more than ever before. Increasingly, they are turning toward no- and low-sugar, and reduced calorie, foods and beverages to help them achieve their weight loss goals (78% of Americans who are trying to lose weight) (CCC 2010). Polyols, found in many of these foods, are becoming a subject of more interest. 6 They are incompletely digested , therefore are sometimes referred to as “low- digestible carbohydrates.” Polyols are not calorie free, as there is some degree of digestion and absorption of the carbohydrate.
    [Show full text]
  • Synthesis, Physicochemical Characterization and Study of the Antimicrobial Activity of Chlorobutanol H
    World Academy of Science, Engineering and Technology International Journal of Pharmacological and Pharmaceutical Sciences Vol:12, No:3, 2018 Synthesis, Physicochemical Characterization and Study of the Antimicrobial Activity of Chlorobutanol H. Nadia, G. Bahdja, S. Thili Malha, Y. Zahoua, D. Taoufik, B. Mourad, M. Marzouk, F. Z. Hadjadj Aoul, L. R. Mekacher I. INTRODUCTION Abstract—Introduction and objectives: Chlorobutanol is a raw XCIPIENTS play a vital role in the design, manufacture material, mainly used as an antiseptic and antimicrobial preservative and preservation of drugs. The addition of an in injectable and ophthalmic preparations. The main objective of our E study was the synthesis and evaluation of the antimicrobial activity of antimicrobial agents is of great interest in the case where the chlorobutanol hemihydrates. Material and methods: Chlorobutanol pharmaceutical preparations do not have adequate was synthesized according to the nucleophilic addition reaction of antimicrobial properties, (especially aqueous preparations), to chloroform to acetone, identified by an infrared absorption using prevent proliferation or limit microbial contamination [1], [2]. Spectrum One FTIR spectrometer, melting point, Scanning electron Chlorobutanol is a trihalogen alcohol with bacteriostatic and microscopy and colorimetric reactions. The dosage of Carvedilol fungistatic activity. The main objective of our work was to active substance was carried out by assaying the degradation products of chlorobutanol in a basic solution. The chlorobutanol obtained was obtain chlorobutanol hemihydrate by chemical synthesis, its subjected to bacteriological tests in order to study its antimicrobial purification and characterization as well as the study of its activity. The antibacterial activity was evaluated against strains such antimicrobial activity. as Escherichia coli (ATCC 25 922), Staphylococcus aureus (ATCC 25 923) and Pseudomonas aeroginosa (ATCC = American type II.
    [Show full text]
  • Quaternary Ammonium Compounds
    FACT SHEET: Quaternary Ammonium Compounds Quaternary ammonium compounds, also known as “quats” or “QACs,” include a number of chemicals used as sanitizers and disinfectants, including benzalkonium chloride, benzethonium chloride, cetalkonium chloride, cetrimide, cetrimonium bromide, cetylpyridinium chloride, glycidyl trimethyl, ammonium chloride, and stearalkonium chloride.[i] In general, quats cause toxic effects through all Mutagenicity routes of exposure including inhalation, Some quats have shown to be mutagenic and to ingestion, dermal application, and irrigation of damage animal DNA and DNA in human body cavities. Exposure to diluted solutions may lymphocytes at much lower levels than are result in mild irritation, while concentrated present in cleaning chemicals.[6] solutions are corrosive, causing burns to the skin and mucous Membranes. They can produce Antimicrobial Resistance systemic toxicity and can also cause allergic Genes have been discovered that mediate reactions.[2] resistance to quats. There has been an association of some of these genes with beta lactamase genes, Asthma and Allergies raising concern for a relationship between Of particular interest with regard to use as disinfectant resistance and antibiotic resistance.[7] disinfectants in the COVID-19 pandemic, quats increase the risk for asthma and allergic Reproductive Toxicity sensitization. Evidence from occupational Mice whose cages were cleaned with QACs had exposures shows increased risk of rhinitis and very low fertility rates. [8] Exposure to a common asthma
    [Show full text]
  • Chloroform 18.08.2020.Pdf
    Chloroform Chloroform, or trichloromethane, is an organic compound with formula CHCl3. It is a colorless, sweet-smelling, dense liquid that is produced on a large scale as a precursor to PTFE. It is also a precursor to various refrigerants. It is one of the four chloromethanes and a trihalomethane. It is a powerful anesthetic, euphoriant, anxiolytic and sedative when inhaled or ingested. Formula: CHCl₃ IUPAC ID: Trichloromethane Molar mass: 119.38 g/mol Boiling point: 61.2 °C Density: 1.49 g/cm³ Melting point: -63.5 °C The molecule adopts a tetrahedral molecular geometry with C3v symmetry. Chloroform volatilizes readily from soil and surface water and undergoes degradation in air to produce phosgene, dichloromethane, formyl chloride, carbon monoxide, carbon dioxide, and hydrogen chloride. Its half-life in air ranges from 55 to 620 days. Biodegradation in water and soil is slow. Chloroform does not significantly bioaccumulate in aquatic organisms. Production:- In industry production, chloroform is produced by heating a mixture of chlorine and either chloromethane (CH3Cl) or methane (CH4). At 400–500 °C, a free radical halogenation occurs, converting these precursors to progressively more chlorinated compounds: CH4 + Cl2 → CH3Cl + HCl CH3Cl + Cl2 → CH2Cl2 + HCl CH2Cl2 + Cl2 → CHCl3 + HCl Chloroform undergoes further chlorination to yield carbon tetrachloride (CCl4): CHCl3 + Cl2 → CCl4 + HCl The output of this process is a mixture of the four chloromethanes (chloromethane, dichloromethane, chloroform, and carbon tetrachloride), which can then be separated by distillation. Chloroform may also be produced on a small scale via the haloform reaction between acetone and sodium hypochlorite: 3 NaClO + (CH3)2CO → CHCl3 + 2 NaOH + CH3COONa Deuterochloroform[ Deuterated chloroform is an isotopologue of chloroform with a single deuterium atom.
    [Show full text]
  • Cascade Catalysis–Strategies and Challenges En Route to Preparative
    ChemComm Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/chemcomm Page 1 of 15 ChemComm ChemComm RSCPublishing Feature article Cascade catalysis – strategies and challenges en route to preparative synthetic biology Cite this: DOI: 10.1039/x0xx00000x Jan Muschiol,a,+ Christin Peters,a,+ Nikolin Oberleitner,b Marko D. Mihovilovic,b Uwe T. Bornscheuera and Florian Rudroffb,* Received 00th January 2012, Accepted 00th January 2012 Nature’s smartness and efficiency assembling cascade type reactions inspired biologists and chemists all around the world. Tremendous effort has been put in the understanding and DOI: 10.1039/x0xx00000x mimicking of such networks. In recent years considerable progress has been made in www.rsc.org/ developing multistep one-pot reactions combining either advantage of chemo-, regio-, and stereoselectivity of biocatalysts or promiscuity and productivity of chemocatalysts.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Comparison of Effectiveness Disinfection of 2%
    ORIGINAL RESEARCH Journal of Dentomaxillofacial Science (J Dentomaxillofac Sci ) December 2018, Volume 3, Number 3: 169-171 P-ISSN.2503-0817, E-ISSN.2503-0825 Comparison of effectiveness disinfection of 2% Original Research glutaraldehyde and 4.8% chloroxylenol on tooth extraction instruments in the Department of Oral CrossMark http://dx.doi.org/10.15562/jdmfs.v3i2.794 Maxillofacial Surgery, Faculty of Dentistry, University of North Sumatera Month: December Ahyar Riza,* Isnandar, Indra B. Siregar, Bernard Volume No.: 3 Abstract Objective: To compare disinfecting effectiveness of 2% glutaraldehyde while the control group was treated with 4.8% chloroxylenol. Each Issue: 2 and 4.8% chloroxylenol on tooth extraction instruments at the instrument was pre-cleaned using a brush, water and soap for both Department of Oral Surgery, Faculty of Dentistry, University of North groups underwent the disinfection process. Sumatera. Results: The results were statistically analyzed using Mann-Whitney Material and Methods: This was an experimental study with post- Test. The comparison between glutaraldehyde and chloroxylenol First page No.: 147 test only control group design approach. Purposive technique is showed a significant difference to the total bacteria count on applied to collect samples which are lower molar extraction forceps. In instrument after disinfection (p=0.014 < 0.05). this study, sample were divided into 2 groups and each consisting of 18 Conclusion: 2% glutaraldehyde was more effective than 4.8% P-ISSN.2503-0817 instruments. The treatment group was treated with 2% glutaraldehyde chloroxylenol at disinfecting lower molar extraction forceps. Keyword: Disinfection, Glutaraldehyde, Chloroxylenol, Forceps E-ISSN.2503-0825 Cite this Article: Riza A, Siregar IB, Isnandar, Bernard.
    [Show full text]
  • Report on Characterisation of New Psychoactive Substances (NPS)
    Report on characterisation of New Psychoactive Substances (NPS) Identification and characterisation of new drugs including physicochemical properties F. Reniero, J. Lobo Vicente, H. Chassaigne, M. Holland, S. Tirendi, K. Kolar , and C. Guillou 2014 European Commission Joint Research Centre Institute for Health & Consumers Protection Contact information Fabiano Reniero Address: Joint Research Centre, Via Enrico Fermi 2749, TP 281, 21027 Ispra (VA), Italy E-mail: [email protected] Tel.: +39 0332 78 9116 https://ec.europa.eu/jrc https://ec.europa.eu/jrc/en/institutes/ihcp / Legal Notice This publication is a Science and Policy Report by the Joint Research Centre, the European Commission’s in-house science service. It aims to provide evidence-based scientific support to the European policy-making process. The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of this publication. All images © European Union 2014 JRC92322 © European Union, 2014 Reproduction is authorised provided the source is acknowledged. Abstract Implementation of the REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on new psychoactive substances within the context of legislative controls on the illicit drugs market requires that enforcement laboratories be provided with fit- for-purpose bio-analytical methods. The aim is to responding to new challenges in the illicit drugs market, where a rapid increase in number and availability of New Psychoactive Substances (NPS) including the combination of licit substances, such as alcohol and prescribed controlled medication, and illicit substances, are faced.
    [Show full text]
  • United States Patent (19) (11) 4,161,571 Yasui Et Al
    United States Patent (19) (11) 4,161,571 Yasui et al. 45 Jul. 17, 1979 (54) PROCESS FOR PRODUCTION OF THE 4,080,493 3/1978 Yasui et al. .......................... 260/879 MALE CANHYDRDE ADDUCT OF A 4,082,817 4/1978 Imaizumi et al. ...................... 526/46 LIQUID POLYMER 4,091,198 5/1978 Smith ..................................... 526/56 75 Inventors: Seimei Yasui, Takarazuka; Takao FOREIGN PATENT DOCUMENTS Oshima, Sonehigashi, both of Japan 2262677 2/1975 France ....................................... 526/56 73) Assignee: Sumitomo Chemical Company, 44-1989 1/1969 Japan ......................................... 526/56 Limited, Osaka, Japan Primary Examiner-William F. Hamrock Attorney, Agent, or Firm-Birch, Stewart, Kolasch and 21 Appl. No.: 843,311 Birch 22 Filed: Oct. 18, 1977 57 ABSTRACT Related U.S. Application Data A process for production of the maleic anhydride ad duct of a liquid polymer having a maleic anhydride 62 Division of Ser. No. 733,914, Oct. 19, 1976, Pat, No. addition amount of 2 to 70% by weight, which com 4,080,493. prises reacting a liquid polymer having a molecular 51 Int. C.’................................................ CO8F 8/46 weight of 150 to 5,000 and a viscosity of 2 to 50,000 cp (52) U.S. C. ...................................... 526/90; 526/192; at 30 C. in the presence of at least one compound, as a 526/209; 526/213; 526/193; 526/195; 526/226; gelation inhibitor, selected from the group consisting of 526/233; 526/237; 526/238; 526/272; 525/285; imidazoles, thiazoles, metallic salts of mercapto 525/249; 525/251; 525/255; 525/245; 525/248 thiazoles, urea derivatives, naphthylamines, nitrosa (58) Field of Search ................
    [Show full text]
  • Dental and Metabolic Effects of Lactitol in the Diet of Laboratory Rats
    Downloaded from British Journal of Nutrition (1989), 61, 17-24 17 https://www.cambridge.org/core Dental and metabolic effects of lactitol in the diet of labolratory rats BY T. H. GRENBY AND A. PHILLIPS Department of Oral Medicine and Pathology, United Medical and Dental Schools, Guy’s Hospital, London SEI 9RT . IP address: (Received 17 May 1988 - Accepted 30 August 1988) 170.106.35.93 I. Because so little is known about the properties of lactitol as a possible alternative bulk sweetener to sucrose, it was tested in two large-scale experiments in laboratory rats. Matched groups of caries-active Osborne-Mendel rats were fed.on uniform diets containing lactitol and compared with a sucrose control in both experiments, plus a xylitol control in the first experiment. , on 2. In the early stages of the experiments weight gains and food utilization were better on the Sucrose than on 26 Sep 2021 at 05:12:03 the lactitol regimens. Body-fat storage was higher on the sucrose than on the polyol regimens. 3. At the end of 8 weeks the mandibular molars were examined for dental plaque accumulation and dental caries. The dental caries scores when 160 g sucrose/kg in the diet was replaced by lactitol were lower by a highly significant margin, bringing them down to the same low level as those on a 160 g xylitol/kg regimen. 4. Testing lactitol in a manufactured food product, shortbread biscuits, in comparison with ordinary sucrose biscuits, showed differences in plaque scores (significant) and caries levels (highly significant), with 60 % fewer lesions on the lactitol regimen.
    [Show full text]